I think that's why CTIX keeps talking about a "combination" therapy, using Kevetrin with another drug. If they can partner with the maker of some big cancer drug, then the drug maker can get people to pay up for TWO drugs instead of one. Get one of the big companies on your side, and then the drug will be pushed, not suppressed.

And then if it turns out Kevetrin works by itself, doctors can stop prescribing the other drug.

Also: what if people take a jolt of Kevetrin every now and then, just to be sure that cancer cells are killed off at an early stage? talk about a big market....

All of this of course hinges on speculation that Kevetrin will prove to be as effective as the Phase 1 hints it MIGHT be.